JPRN-UMIN000014298已完成未知
Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitors - Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitors
aka Kinen Clinic0 个研究点目标入组 20 人开始时间: 2014年6月18日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Type-1 diabetes, diabetes due to a pancreatic disorder, or secondary diabetes due to conditions such as Cushing's syndrome and acromegaly (2) Application of contraindications contained in the package insert (3) Excessive alcohol consumption : mean daily intake of pure alcohol >=60g (4) Pregnant women, women suspected of being pregnant, or lactating women (5) Participation in the study is judged by the investigator or sub-investigator as inappropriate for any other reason
研究者
相似试验
已完成
不适用
The efficacy of teneligliptin in patients with type 2 diabetes mellitusdiabetes mellitusJPRN-UMIN000028763Juntendo University Urayasu Hospital30
尚未招募
3 期
Study on Obesity management in non diabeticsCTRI/2020/02/023329Self financed
已完成
4 期
Clinical Study for the Effect of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-UMIN000014589TOPLEVEL study office936
进行中（未招募）
4 期
TOPLEVEL studyType 2 Diabetes MellitusJPRN-jRCTs051180136Kitakaze Masafumi936
已完成
不适用
The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.Type 2 diabetic patients with nephropathyJPRN-UMIN000015922Kanazawa Medical University50